New trends for osteoarthritis: Biomaterials, models and modeling.

This research paper discusses recent advancements in treating osteoarthritis (OA), including new drug delivery methods, better animal models to test therapies, and the development of 3D in-vitro models for cartilage.

New OA Drug Delivery Approaches

• The researchers touch on several novel drug delivery systems being developed for OA. These include lubrication-based biomaterials, hydrogels, liposomes, dendrimers, and various types of particles. These substances can carry drugs directly to the site of the disease, improving treatment efficacy and possibly reducing side effects.

Animal Models for Evaluating Therapies

• The paper highlights the use of large and small animal models for testing OA therapeutic strategies. Horses have long been used in OA research due to their similar cartilage thickness and disease features to humans. Recently, zebrafish have gained popularity as a model due to their fast generation time and the ease of genetically manipulating them.

In-Vitro Modeling

• Lastly, the article delves into in-vitro modeling advancements, especially the use of 3D models of cartilage, also known as organoids. Such models offer a more realistic simulation of the human body compared to traditional 2D cell culture systems. They allow scientists to analyze the disease and potential treatments in a controlled environment, while reducing the number of animals used in experimentation, adhering to the 3R (Replace, Reduce, Refine) principle of animal experimentation.